↓ Skip to main content

Dove Medical Press

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

Overview of attention for article published in Cancer Management and Research, January 2013
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
105 Mendeley
Title
Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
Published in
Cancer Management and Research, January 2013
DOI 10.2147/cmar.s25537
Pubmed ID
Authors

Michael R Harrison, Terence Z Wong, Andrew J Armstrong, Daniel J George

Abstract

Radium-223 chloride ((223)Ra; Alpharadin) is an alpha-emitting radioisotope that targets areas of osteoblastic metastasis and is excreted by the small intestine. When compared with beta-emitters (eg, strontium-89, samarium-153), (223)Ra delivers a high quantity of energy per track length with short tissue penetration.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 2 2%
United Kingdom 1 <1%
United States 1 <1%
Switzerland 1 <1%
Unknown 100 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 15%
Student > Master 14 13%
Student > Ph. D. Student 13 12%
Student > Bachelor 10 10%
Student > Postgraduate 10 10%
Other 31 30%
Unknown 11 10%
Readers by discipline Count As %
Medicine and Dentistry 41 39%
Physics and Astronomy 11 10%
Agricultural and Biological Sciences 10 10%
Biochemistry, Genetics and Molecular Biology 7 7%
Engineering 6 6%
Other 16 15%
Unknown 14 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2013.
All research outputs
#22,758,309
of 25,373,627 outputs
Outputs from Cancer Management and Research
#1,470
of 2,074 outputs
Outputs of similar age
#258,406
of 288,991 outputs
Outputs of similar age from Cancer Management and Research
#3
of 4 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,074 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,991 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.